Interim report for Q3
- The Technology››
- Healthcare associated infections››
- About Bactiguard››
Our technology is well-proven, safe and patient friendly. It is based on a thin noble metal coating firmly attached to the surface of medical devices, prevents bacteria from adhering and biofilm formation, which reduces the amount of healthcare associated infections significantly.
Healthcare associated infections (HAI) is a global threat, that can affect everyone when seeking care at a hospital. About 6 million people are affected every year and 150 000 of them die by an infection. More than half of the infections are caused by medical devices.
Bactiguard is a Swedish medtech company offering an effective and patient friendly solution for infection prevention.
Our patented technology has unlimited application potential.
We offer products preventing healthcare associated infections caused by medical devices for the urinary tract, respiratory tract and the bloodstream.
Everything you need to know about healthcare associated infections.
Bactiguard Holding AB (publ) published the interim report for the second quarter on Thursday August 13, 2020 at 07:30 CET. In connection with this, a webcast for investors, analysts and media was held at 10:00 CET on August 13 where CEO Cecilia Edström presented the interim report and answered questions. Bactiguard's new CFO Gabriella Björknert Caracciolo also participated.
Please find the webcast below:
Every year millions of people are affected by healthcare associated infections, causing great patient suffering. Bactiguard´s antimicrobial and preventive solution reduces the number of healthcare associated infections related to the use of medical devices. By reducing healthcare associated infections we increase patient safety, reduce the use of antiobiotics ant thereby prevent the spread of multi-resistant bacteria, save significant costs for the healthcare system and most important of all, we save lives.
Bactiguard Holding AB (publ) published the interim report for the second quarter on Thursday August 13, 2020 at 07:30 CET.
In connection with this, a webcast for investors, analysts and media was hold at 10:00 CET on August 13, where CEO Cecilia Edström presented the interim report and answered questions. Bactiguard's new CFO Gabriella Björknert Caracciolo did also participate.
Link to the webcast: https://tv.streamfabriken.com/bactiguard-q2-2020
Link to the report: Q2 20202 report >>>
Stories from reality
"The quality of my Life has really improved"